Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Fox's (FOX, FOXA) new streaming service, Fox One; SoftBank (9434.T) delaying its $100 billion investment into AI infrastructure in the US; and patients using Eli Lilly's (LLY) Zepbound reporting losing more weight than Novo Nordisk's (NVO) Wegovy GLP-1 weight-loss drug. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. Video Transcript 00:00 Speaker A We are two hours into the trading day and it's time for Yahoo Finance's market minute. Stocks climbing as President Trump says that China agreed to open up to US business during trade talks. The US and China agreeing to reduce tariffs for the next 90 days. Fox revealing its upcoming standalone streaming service will be called Fox One. The service will debut ahead of the fall NFL season. Cable subscribers will receive a subscription for no additional cost. Bundles will also be available. And SoftBank's planned $100 billion investment in US artificial intelligence infrastructure announced in January is hitting tariff related delays, according to Bloomberg. And according to a new study funded by Eli Lilly, after 72 weeks, patients on Lilly's Zebound lost more weight than those on Novo Nordisk's Wegovy. And that is your Yahoo Finance market minute. For more, you can scan the QR code below to track the best and worst performing stocks of the session. Related Videos 09:45 Biocon Executive Chairperson on Insulin Capacity Bloomberg • 10 hours ago 02:03 3 major takeaways from Novo Nordisk's Q1 earnings Yahoo Finance Video • 4 days ago 06:10 Novo Nordisk CEO on earnings, GLP-1 deal with CVS, manufacturing Yahoo Finance Video • 5 days ago 05:21 Novo Nordisk CFO on Wegovy, Tariffs, US Compounding Bloomberg • 5 days ago View Comments
Fox One, SoftBank delays investment, Zepbound weight loss
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...